A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

Clinical trial NCT07217301 · RECRUITING

Trial details

NCT number: NCT07217301
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IO-resistant sqNSCLC

Start date: 2025-11-26
Primary completion: 2028-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.